Dr. Ayed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Shircliff Way
Mary Virginia Terry Cancer Center
Jacksonville, FL 32204Phone+1 904-388-2619Fax+1 904-388-0240
Summary
- Dr. Ayed is an oncologist who is dedicated to the delivery of high-quality cancer care and contributing to cancer education and research. The core philosophy of his practice is the adoption of an evidence-based, multidisciplinary and collaborative approach with strong emphasis on patient involvement and trust. He obtained his M.D. degree with honors from the University of Jordan and completed his internal medicine training at the University of Florida. He completed fellowship training in Hematology and Medical Oncology at the Mayo Clinic in Rochester, Minnesota. His clinical research interests include blood cancers, primarily non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of FloridaResidency, Internal Medicine, 2012 - 2015
University of Jordan Faculty of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2018 - 2026
MN State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 22 citationsConsensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji
Blood. 2024-04-18 - Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.Jacqueline C Barrientos, Ayed O Ayed, Agnes Cha, Senxi Du, Bruno Fang
Targeted Oncology. 2023-09-01 - 5 citationsManagement of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.Ayed O. Ayed, Sameer A. Parikh
Leukemia & Lymphoma. 2018-10-03
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
